Last reviewed · How we verify
NCT02717390
Bright by Three (BB3) Effectiveness Study
NA trial testing Bright By Three (BB3) in Developmental Delay in 100 participants. Terminated before completion.
30 March 2019
Quick facts
| Lead sponsor | University of Colorado, Denver |
|---|---|
| Phase | NA |
| Status | Terminated |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | prevention |
| Enrollment | 100 |
| Start date | 1 August 2017 |
| Primary completion | 30 March 2019 |
| Estimated completion | 30 March 2019 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Bright By Three (BB3)
- Texts for Child Safety (TCS)
Conditions studied
- Developmental Delay — all drugs for Developmental Delay →
Sponsor
University of Colorado, Denver
Who can join
Adults 12 Months to 15 Months, any sex, with Developmental Delay. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The Investigators propose to conduct a pragmatic randomized controlled trial of 350 one to four year old children and their caregivers to study the effectiveness of 1) the Bright By Three (BB3) intervention for promoting children's language and socio-emotional development and 2) a modified version of the Safe 'N Sound (SNS) intervention for reducing safety hazards and injuries. The SNS intervention will serve as a control for the BB3 group and vice versa so that all study participants will receive a clinically meaningful intervention. In collaboration with primary care clinics that serve low-income and minority children, the Investigators will recruit and randomize 350 twelve to fifteen month olds and their parents/caregivers to one of the two intervention arms and deliver the interventions over a 2 year period.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Engage, Develop, Learn: a pilot randomized clinical trial to test if a mobile application can enhance home support for early cognitive development among children living in poverty.
Cunningham MA, Gorman C, McNulty MC, Chavez C, et al · · 2023 · cited 3× · PMID 36760785 · DOI 10.21037/mhealth-22-13
Verify or expand the search:
- PubMed search for NCT02717390
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Developmental Delay
Currently open trials in the same condition.
- NCT07524192 — A Self-Instructional Online Program for Early Childhood and Elementary Teachers Supporting Autistic Children and Childre · NA · recruiting
- NCT07307105 — Comparative Effects Of Creative Movement & Play Based Interventions On Motor Skills · NA · active not recruiting
- NCT06423664 — Improving Neurodevelopmental ouTcomes After Prenatal Cannabinoid in uTero Exposure · NA · recruiting
- NCT06458959 — Exploratory Trial of a Pediatric Web-Based Care Planning Guide · NA · active not recruiting
- NCT06145659 — School-based Support for Pre-school Aged Children With Developmental Disabilities and Delays · NA · recruiting
Other University of Colorado, Denver trials
Trials by the same sponsor.
- NCT07292285 — The Surveillance Nonoperative Watch & Wait (SNOWW) Rectal Cancer Trial. · not yet recruiting
- NCT07021937 — Brain Plasticity and GLP-1 Receptor Agonist Treatment for Obesity · Phase 3 · not yet recruiting
- NCT07453732 — Banana Leaves as a Wound Dressing for Partial Thickness Second Degree Burns in Adult Patients. · NA · not yet recruiting
- NCT07038278 — 5-AminoLevulinic Acid Aided Resection Margins in Sarcoma · EARLY_PHASE1 · not yet recruiting
- NCT07279558 — Cannabidiol and Alcohol Use Disorder Phenotypes · Phase 2 · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT02717390 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Colorado, Denver
- Last refreshed: 4 November 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02717390.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing